259 related articles for article (PubMed ID: 29696300)
41. What is the fate of insignificant residual fragment following percutaneous nephrolithotomy in pediatric patients with anomalous kidney? A comparison with normal kidney.
Purkait B; Sinha RJ; Bansal A; Sokhal AK; Singh K; Singh V
Urolithiasis; 2018 Jun; 46(3):285-290. PubMed ID: 28478480
[TBL] [Abstract][Full Text] [Related]
42. Ureteropyeloscopic treatment of large, complex intrarenal and proximal ureteral calculi.
Cohen J; Cohen S; Grasso M
BJU Int; 2013 Mar; 111(3 Pt B):E127-31. PubMed ID: 22757752
[TBL] [Abstract][Full Text] [Related]
43. 5-year-follow-up of patients with clinically insignificant residual fragments after extracorporeal shockwave lithotripsy.
Osman MM; Alfano Y; Kamp S; Haecker A; Alken P; Michel MS; Knoll T
Eur Urol; 2005 Jun; 47(6):860-4. PubMed ID: 15925084
[TBL] [Abstract][Full Text] [Related]
44. Long-term follow-up after primary extracorporeal shockwave lithotripsy monotherapy of staghorn calculi: results after more than 6 years.
Mattelaer P; Wolff JM; Jung P; Feistkorn C; Jakse G
Acta Urol Belg; 1997 Oct; 65(3):41-5. PubMed ID: 9421936
[TBL] [Abstract][Full Text] [Related]
45. Percutaneous nephrolithotomy for pediatric renal calculus disease: 5 years of local experience.
Romanowsky I; Lismer L; Asali M; Rosenberg E; Kaneti J
Arch Ital Urol Androl; 2008 Jun; 80(2):56-8. PubMed ID: 18683810
[TBL] [Abstract][Full Text] [Related]
46. What happens to asymptomatic lower pole kidney stones smaller than 10 mm in children during watchful waiting?
Telli O; Hamidi N; Bagci U; Demirbas A; Hascicek AM; Soygur T; Burgu B
Pediatr Nephrol; 2017 May; 32(5):853-857. PubMed ID: 28070668
[TBL] [Abstract][Full Text] [Related]
47. Meta-analysis of Optimal Management of Lower Pole Stone of 10 - 20 mm: Flexible Ureteroscopy (FURS) versus Extracorporeal Shock Wave Lithotripsy (ESWL) versus Percutaneus Nephrolithotomy (PCNL).
Yuri P; Hariwibowo R; Soeroharjo I; Danarto R; Hendri AZ; Brodjonegoro SR; Rasyid N; Birowo P; Widyahening IS
Acta Med Indones; 2018 Jan; 50(1):18-25. PubMed ID: 29686172
[TBL] [Abstract][Full Text] [Related]
48. Retrograde ureteropyeloscopic treatment of 2 cm. or greater upper urinary tract and minor Staghorn calculi.
Grasso M; Conlin M; Bagley D
J Urol; 1998 Aug; 160(2):346-51. PubMed ID: 9679874
[TBL] [Abstract][Full Text] [Related]
49. Is ureteroscopy first line treatment for pediatric stone disease?
Smaldone MC; Cannon GM; Wu HY; Bassett J; Polsky EG; Bellinger MF; Docimo SG; Schneck FX
J Urol; 2007 Nov; 178(5):2128-31; discussion 2131. PubMed ID: 17870124
[TBL] [Abstract][Full Text] [Related]
50. Long-term outcomes of percutaneous nephrolithotomy compared to shock wave lithotripsy and conservative management.
Krambeck AE; LeRoy AJ; Patterson DE; Gettman MT
J Urol; 2008 Jun; 179(6):2233-7. PubMed ID: 18423676
[TBL] [Abstract][Full Text] [Related]
51. Analysis of 24-hour urine parameters as it relates to age of onset of cystine stone formation.
Lambert EH; Asplin JR; Herrell SD; Miller NL
J Endourol; 2010 Jul; 24(7):1179-82. PubMed ID: 20624086
[TBL] [Abstract][Full Text] [Related]
52. Impact of a metabolic stone clinic on management of patients with cystinuria: 5 years follow-up.
Haritopoulos K; Fojtik P; Cross W; Cartledge J
Clin Ter; 2010; 161(4):341-4. PubMed ID: 20931157
[TBL] [Abstract][Full Text] [Related]
53. A low or high BMI is a risk factor for renal hematoma after extracorporeal shock wave lithotripsy for kidney stones.
Nussberger F; Roth B; Metzger T; Kiss B; Thalmann GN; Seiler R
Urolithiasis; 2017 Jun; 45(3):317-321. PubMed ID: 27576325
[TBL] [Abstract][Full Text] [Related]
54. Imaging and surgical utilization for pediatric cystinuria patients: A single-institution cohort study.
Varda BK; Johnson EK; Johnson KL; Rosoklija I; Baum MA; Nelson CP
J Pediatr Urol; 2016 Apr; 12(2):106.e1-7. PubMed ID: 26597229
[TBL] [Abstract][Full Text] [Related]
55. A new nomogram for prediction of outcome of pediatric shock-wave lithotripsy.
Dogan HS; Altan M; Citamak B; Bozaci AC; Karabulut E; Tekgul S
J Pediatr Urol; 2015 Apr; 11(2):84.e1-6. PubMed ID: 25812469
[TBL] [Abstract][Full Text] [Related]
56. Durability of the medical management of cystinuria.
Pietrow P; Auge BK; Weizer AZ; Delvecchio FC; Silverstein AD; Mathias B; Albala DM; Preminger GM
J Urol; 2003 Jan; 169(1):68-70. PubMed ID: 12478105
[TBL] [Abstract][Full Text] [Related]
57. Extracorporeal shock wave lithotripsy in prepubertal children: 22-year experience at a single institution with a single lithotriptor.
Landau EH; Shenfeld OZ; Pode D; Shapiro A; Meretyk S; Katz G; Katz R; Duvdevani M; Hardak B; Cipele H; Hidas G; Yutkin V; Gofrit ON
J Urol; 2009 Oct; 182(4 Suppl):1835-9. PubMed ID: 19692011
[TBL] [Abstract][Full Text] [Related]
58. Cystine urolithiasis in Finland.
Ala-Opas M
Ann Chir Gynaecol; 1989; 78(2):136-41. PubMed ID: 2802494
[TBL] [Abstract][Full Text] [Related]
59. Pediatric ureteroscopic stone management.
Thomas JC; DeMarco RT; Donohoe JM; Adams MC; Brock JW; Pope JC
J Urol; 2005 Sep; 174(3):1072-4. PubMed ID: 16094060
[TBL] [Abstract][Full Text] [Related]
60. Predictors for kidney stones recurrence following extracorporeal shock wave lithotripsy (ESWL) or percutaneous nephrolithotomy (PCNL).
Chongruksut W; Lojanapiwat B; Tawichasri C; Paichitvichean S; Euathrongchit J; Ayudhya VC; Patumanond J
J Med Assoc Thai; 2012 Mar; 95(3):342-8. PubMed ID: 22550832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
